中文版

Nancy Chang

Renowned Entrepreneur in Biology and Healthcare Industry、senior adviser


Dr. Nancy T. Chang has served as the CEO at Ansun Biopharma since 2011. Since 2007, Dr. Chang has served as the President of Apex Enterprises, Inc., an investment management company with a major focus on healthcare investments.
From 2007 to 2012, she was the Chairperson and Senior Managing Director of Caduceus Asia Partners at OrbiMed Advisors.

From 1987 to 2007, Dr. Chang served as Co-Founder, President and Chairman of Tanox, Inc. which went IPO in 2000 and reached $1 billion in valuation and then was acquired by Genentech in 2007. Prior to founding Tanox, Dr. Chang held several leadership positions at Centocor, now a division of Johnson & Johnson.

She was also an Associate Professor at Baylor College of Medicine. Before that, Dr. Chang worked at the Roche Institute of Molecular Biology. She has served on the boards of a number of companies, including Charles River Laboratories International, Inc. and Applied Optoelectronics Inc. She is currently a member of the board of directors of SciClone Pharmaceuticals, Inc.

In addition, Dr. Chang was a member of the board of directors at the Biotechnology Industry Organization (BIO)and BioHouston. Dr. Chang also was a Director at the Federal Reserve Bank in the Dallas Houston Branch, and was a Director for Project Hope. She has published more than 35 papers on topics ranging from monoclonal antibodies to HIV and holds seven patents.

Dr. Chang received her Doctorate in Biological Chemistry from Harvard University.